Enanta Pharmaceuticals (ENTA) Tax Provisions (2016 - 2025)
Historic Tax Provisions for Enanta Pharmaceuticals (ENTA) over the last 12 years, with Q4 2025 value amounting to $24000.0.
- Enanta Pharmaceuticals' Tax Provisions rose 10576.92% to $24000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.3 million, marking a year-over-year increase of 2300.58%. This contributed to the annual value of -$1.8 million for FY2025, which is 847.11% up from last year.
- According to the latest figures from Q4 2025, Enanta Pharmaceuticals' Tax Provisions is $24000.0, which was up 10576.92% from -$80000.0 recorded in Q3 2025.
- In the past 5 years, Enanta Pharmaceuticals' Tax Provisions registered a high of $7.1 million during Q1 2021, and its lowest value of -$9.4 million during Q2 2021.
- Over the past 5 years, Enanta Pharmaceuticals' median Tax Provisions value was -$363000.0 (recorded in 2024), while the average stood at -$660789.5.
- Over the last 5 years, Enanta Pharmaceuticals' Tax Provisions had its largest YoY gain of 104429.53% in 2023, and its largest YoY loss of 7040000.0% in 2023.
- Enanta Pharmaceuticals' Tax Provisions (Quarter) stood at -$36000.0 in 2021, then increased by 5.56% to -$34000.0 in 2022, then plummeted by 1729.41% to -$622000.0 in 2023, then soared by 33.12% to -$416000.0 in 2024, then surged by 105.77% to $24000.0 in 2025.
- Its Tax Provisions stands at $24000.0 for Q4 2025, versus -$80000.0 for Q3 2025 and $29000.0 for Q2 2025.